Skip to main content
Premium Trial:

Request an Annual Quote

HP, Partners HealthCare Extend Personalized Medicine Collaboration

NEW YORK (GenomeWeb News) – Hewlett Packard and Partners HealthCare have extended an ongoing agreement to develop software and implement hardware and services supporting Partners' personalized medicine and clinical genomics program, HP said today.

Under the five-year, "multi-million dollar" agreement, HP will extend Partners' IT infrastructure, with a particular focus on data storage capabilities to handle data from next-generation sequencing programs. The increase in genetic and genomic data output from new sequencing technologies requires a "cost-effective, high-performance computing storage environment," HP said.

The collaboration so far has benefited the Partners HealthCare Center for Personalized Medicine (PCPGM) by creating a large mini-cluster computer facility to support Partners' genetics researchers.

That infrastructure allowed PCPGM and HP to collaborate on the creation of the Gateway for Integrated Genomics-Proteomics Application and Data, which integrates disparate lab systems, provides a portal to submit and access bio-samples, and helps in managing workflows and data repositories.

The software solution developed at PCPGM is a component of the HP Digital Discovery and Development Solution, a collaborative architecture that enables translational research for life sciences companies.

"We believe the vision of personalized medicine, where clinicians are able to make diagnostic, treatment and clinical management decisions based on a patient's genetic profile, can only be realized by leveraging IT infrastructure that can keep pace with the fast rate of change in the genomics field," Partners Chief Information Officer John Glaser said in a statement.

Partners HealthCare is an integrated health system that was founded by Brigham and Women's Hospital and Massachusetts General Hospital.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.